 REDWOOD CITY, CA ACCESSWIRE August 26, 2021 Biotricity, Inc. OTCQB: BTCY, a medical diagnostic and consumer healthcare technology company, today announced the pricing of an underwritten public offering of 5,000,000 shares of common stock of the Company, at a price of 3.00 per share for total gross proceeds to the Company of approximately 15 million. In addition, the Company has granted the underwriter of the offering a 30-day option to purchase an additional 750,000 shares of common stock at the public offering price, less underwriting discounts and commissions. 